Q
Q-Line Biotech Ltd.
SMEListedListed on 29 May 2026+31.8%
Price Range
₹326–343
Issue Size
₹ 153 Cr
Lot Size
800 Shares
Min. Investment
₹ 2,60,800
Historical Financials
Annual consolidated / standalone figures
| Particulars | FY 2022-23 | FY 2023-24 | FY 2024-25 |
|---|---|---|---|
| Operating Revenue (₹ Cr) | 18,273.63 | 20,364.61 | 31,378.04 |
| Other Income (₹ Cr) | 207.52 | 280.2 | 880.38 |
| Total Income (₹ Cr) | 18,481.15 | 20,644.81 | 32,258.42 |
| Total Expenses (₹ Cr) | 14,898.5 | 16,558.35 | 23,929.3 |
| Profit Before Tax (₹ Cr) | 2,984.01 | 3,060.17 | 4,419.23 |
| PAT (₹ Cr) | 2,138.25 | 2,164.21 | 2,451.37 |
| Net Worth (₹ Cr) | 12,736.52 | 16,181.44 | 18,994.53 |
| Borrowings (₹ Cr) | 0 | 0 | 0 |
| EPS (₹) | 20.38 | 21.87 | 28.63 |
| ROE (%) | 16.79 | 14.97 | 13.94 |